 | Seres Therapeutics (NASDAQ:MCRB) Price Target Increased to $42.00 by Analysts at Canaccord Genuity
marketbeat.com - September 21 at 7:42 AM |
| Seres Therapeutics (NASDAQ:MCRB) Earns Overweight Rating from Analysts at Piper Sandler
marketbeat.com - August 18 at 7:15 AM |
 | Seres Therapeutics (NASDAQ:MCRB) Stock Price Up 7.3%
americanbankingnews.com - September 29 at 7:02 PM |
| Analyzing Seres Therapeutics (NASDAQ:MCRB) and Catalyst Biosciences (NASDAQ:CBIO)
americanbankingnews.com - September 22 at 7:37 PM |
| Seres Therapeutics (NASDAQ:MCRB) PT Raised to $42.00 at Canaccord Genuity
americanbankingnews.com - September 21 at 8:36 AM |
 | Chardan downgrades Seres Therapeutics to Neutral
seekingalpha.com - September 18 at 7:32 PM |
| Chardan Capital Downgrades Seres Therapeutics (NASDAQ:MCRB) to Neutral
americanbankingnews.com - September 18 at 10:48 AM |
| Analyzing BELLUS Health (NASDAQ:BLU) & Seres Therapeutics (NASDAQ:MCRB)
americanbankingnews.com - September 18 at 9:18 AM |
 | Microbiome startup raises $90M as it prepares for a potential FDA first
bizjournals.com - September 17 at 8:27 AM |
| Seres Therapeutics (NASDAQ:MCRB) Trading 5.9% Higher
americanbankingnews.com - September 14 at 9:50 PM |
|
 | Seres Therapeutics to Present at Upcoming Investor Conferences
finance.yahoo.com - September 14 at 7:36 AM |
| Seres Therapeutics (NASDAQ:MCRB) Earns Buy Rating from Oppenheimer
americanbankingnews.com - September 14 at 6:16 AM |
| Contrasting Seres Therapeutics (NASDAQ:MCRB) and Adamis Pharmaceuticals (NASDAQ:ADMP)
americanbankingnews.com - September 11 at 1:39 PM |
| Seres Therapeutics receives FDA feedback for SER-109 marketing application
seekingalpha.com - September 11 at 8:15 AM |
| Seres Therapeutics closing in on U.S. application for C. diff candidate SER-109
seekingalpha.com - September 11 at 8:15 AM |
| Seres Therapeutics Announces U.S. Food and Drug Administration Correspondence Following Positive SER-109 Phase 3 Study Results
finance.yahoo.com - September 11 at 8:15 AM |
| The Seres Therapeutics (NASDAQ:MCRB) Share Price Has Soared 590%, Delighting Many Shareholders
finance.yahoo.com - August 21 at 3:09 PM |
 | Will Seres Therapeutics Inc's price keep rising?
uk.finance.yahoo.com - August 14 at 2:37 PM |
| Why Seres Therapeutics Stock Surged Today
finance.yahoo.com - August 13 at 6:44 PM |
| Seres Therapeutics prices equity offering at $21.50
seekingalpha.com - August 13 at 8:43 AM |
| Seres Therapeutics, Inc. Announces Pricing of Public Offering of 10,500,000 Shares of Common Stock
finance.yahoo.com - August 13 at 12:04 AM |
 | Seres Therapeutics Reaches Analyst Target Price
nasdaq.com - August 11 at 5:57 PM |
| Seres Therapeutics Stock Scales Nasdaq on Positive Drug Data
finance.yahoo.com - August 10 at 6:37 PM |
| Why Seres Therapeutics Stock Skyrocketed 350% Today
finance.yahoo.com - August 10 at 6:37 PM |
 | Good News for C Diff Sufferers and Seres Therapeutics Investors
msn.com - August 10 at 1:31 PM |
| Seres stock jumps 400% on microbiome trial success
bizjournals.com - August 10 at 1:31 PM |
| Stock Alert: Seres Therapeutics Soars 300% On Positive Data From Trial Of Colon Infection Drug
nasdaq.com - August 10 at 1:31 PM |
 | Return On Capital Employed Overview: Seres Therapeutics
benzinga.com - August 10 at 1:31 PM |
| Seres Therapeutics Skyrockets On Positive Pivotal Study Results For Microbiome Therapeutic
msn.com - August 10 at 1:31 PM |
| This Tiny Biotech's Shares Quadruple After Late-Stage Drug Tests Succeed
finance.yahoo.com - August 10 at 1:31 PM |
| Seres Therapeutics up big on success of lead drug in C. diff study
seekingalpha.com - August 10 at 8:31 AM |
| Seres Therapeutics Announces Positive Topline Results from SER-109 Phase 3 ECOSPOR III Study in Recurrent C. difficile Infection
finance.yahoo.com - August 10 at 8:31 AM |
|
| Do Options Traders Know Something About Seres Therapeutics (MCRB) Stock We Don't?
nasdaq.com - August 7 at 1:35 PM |
| Do Options Traders Know Something About Seres Therapeutics (MCRB) Stock We Don't?
finance.yahoo.com - August 7 at 1:35 PM |
| Recap: Seres Therapeutics Q2 Earnings
finance.yahoo.com - July 28 at 1:36 PM |
| Earnings Preview: Seres Therapeutics (MCRB) Q2 Earnings Expected to Decline
finance.yahoo.com - July 28 at 1:36 PM |
| Seres Therapeutics Reports Second Quarter 2020 Financial Results and Provides Business Updates
finance.yahoo.com - July 28 at 8:35 AM |
| Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing
finance.yahoo.com - July 7 at 8:19 AM |
| Seres Therapeutics Appoints Terri Young, Ph.D., R.Ph., Experienced Commercial Leader, as Executive Vice President, Chief Commercial and Strategy Officer
finance.yahoo.com - June 22 at 10:25 AM |
| The pandemic upended clinical trials. Biotechs are now restarting them.
www.bizjournals.com - June 5 at 1:00 PM |
| Seres Therapeutics to Present at the Goldman Sachs 41st Annual Global Virtual Healthcare Conference
finance.yahoo.com - June 2 at 7:37 PM |
| Implied Volatility Surging for Seres Therapeutics (MCRB) Stock Options
finance.yahoo.com - June 2 at 9:21 AM |
| Hedge Funds Have Never Been Less Bullish On Seres Therapeutics Inc (MCRB)
finance.yahoo.com - June 1 at 12:05 AM |
| Seres Therapeutics to Present at Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 28 at 8:49 AM |
| Seres Therapeutics to Host Virtual SER-109 Focused Symposium on May 27, 2020, Ahead of Phase 3 ECOSPOR III Study Read-Out
finance.yahoo.com - May 18 at 10:01 AM |
| Seres Therapeutics Reports Weak Earnings, But Significant Upside Lies Ahead
finance.yahoo.com - May 11 at 4:37 AM |
| Seres Therapeutics, Inc. (MCRB) CEO Eric Shaff on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 6:42 AM |
 | Seres Therapeutics Inc (MCRB) Q1 2020 Earnings Call Transcript
www.fool.com - May 9 at 1:34 PM |
| Edited Transcript of MCRB earnings conference call or presentation 7-May-20 12:30pm GMT
finance.yahoo.com - May 8 at 6:31 PM |
| Seres Therapeutics (MCRB) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 7 at 1:09 PM |
| Seres Therapeutics EPS misses by $0.02, misses on revenue
seekingalpha.com - May 7 at 8:08 AM |
| Seres Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates
finance.yahoo.com - May 7 at 8:08 AM |
